ZL-1310 earns fast track designation in extensive-stage small cell lung cancer after early trial data showed tumor shrinkage ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

At 34, non-smoker Reyna Savage mistook persistent shoulder pain for a gym injury, only to be diagnosed with stage 4 non-small ...

Zai Lab Limited ( NASDAQ: ZLAB) said on Monday that it received U.S. FDA fast track designation for its antibody-drug ...

A new study published in the Annals of Surgical Oncology revealed that individuals with little muscle mass, segmentectomy ...

OncoHost has won a €2.5m ($2.8m) grant to develop a novel biomarker capable of predicting cancer patient responses to immunotherapy.

The FDA has approved MSD’s Welireg for rare adrenal tumours, and AbbVie’s Emrelis for treating c-Met+ lung cancer patients.

A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...

Targeting clonal antigens and circumventing dysfunctional states may be important for conferring clinical responses to TIL therapy.

UbiVac’s DPV-001 induces Development of 1st in-patient generated TCR to Non-Small Cell Lung Cancer’s “Dark Matter” – Targets cancer without apparent toxicity UbiVac is thrilled to announce the first ...

Previous research in Manchester using radiotherapy planning images identified the top of the heart as a particularly radiosensitive area in lung cancer patients, with radiation dose to this region ...

TNM Classification for Lung Cancer (18). Clinical features and disease progression were assessed by reviewing patient charts and radiographic images. ALK rearrangements were identified using at least ...